| Company Name: |
Shanghai Chaolan Chemical Technology Center
|
| Tel: |
QQ:65489617 15618227136 |
| Email: |
info@SuperLan-chem.com |
| Products Intro: |
Product Name:EP4 receptor antagonist 1
CAS:2287259-07-6
Purity:98% Package:5MG;10MG;50MG;100MG,1G,5G,100G
|
|
| | EP4 receptor antagonist 1 Basic information |
| Product Name: | EP4 receptor antagonist 1 | | Synonyms: | EP4 receptor antagonist 1;HEK293,Prostaglandin Receptor,EP4,immunotherapy,Inhibitor,inhibit,EP4 receptor antagonist 1,EP-4 receptor antagonist 1,cells,cancer;Benzoic acid, 4-[(1S)-1-[[[4-(1E)-1-propen-1-yl-1-[[4-(trifluoromethyl)phenyl]methyl]-1H-1,2,3-triazol-5-yl]carbonyl]amino]ethyl]-;4-[(1S)-1-[[[4-(1E)-1-propen-1-yl-1-[[4-(trifluoromethyl)phenyl]methyl]-1H-1,2,3-triazol-5-yl]carbonyl]amino]ethyl]-benzoic acid | | CAS: | 2287259-07-6 | | MF: | C23H21F3N4O3 | | MW: | 458.43 | | EINECS: | | | Product Categories: | | | Mol File: | 2287259-07-6.mol |  |
| | EP4 receptor antagonist 1 Chemical Properties |
| density | 1.32±0.1 g/cm3(Predicted) | | storage temp. | Store at -20°C | | solubility | DMF: 30 mg/ml,DMSO: 30 mg/ml,DMSO:PBS (pH 7.2) (1:6): 0.14 mg/ml | | form | A crystalline solid | | pka | 4.19±0.10(Predicted) | | color | White to off-white |
| | EP4 receptor antagonist 1 Usage And Synthesis |
| Biological Activity | EP4 receptor antagonist 1 is an antagonist of the prostaglandin E2 (PGE2) receptor EP4 that has an IC50 value of 6.1 nM in a calcium flux assay using CHO cells co-expressing the human receptor and Gα16.1 It is selective for EP4 over EP1, EP2, and EP3 receptors (IC50s = >10,000 nM for all). EP4 receptor antagonist 1 inhibits PGE2-induced β-arrestin recruitment in HEK293 cells expressing EP4. It reverses ERK phosphorylation induced by PGE2 in CHO cells expressing EP4 and decreases GM-CSF-induced expression of Il1b, Il4ra, Il6, Arg1, Cox2, and Il10 in RAW 264.7 cells when used at a concentration of 10 μM. EP4 receptor antagonist 1 (50 and 150 mg/kg once per day) reduces tumor volume and increases infiltration of CD8+ T cells into tumors in a murine colon carcinoma model. | | References | 1.Yang, J.-J., Yu, W.-W., Hu, L.-L., et al.Discovery and characterization of 1 H-1,2,3-triazole derivatives as novel prostanoid EP4 receptor antagonists for cancer immunotherapyJ. Med. Chem.63(2)569-590(2020) |
| | EP4 receptor antagonist 1 Preparation Products And Raw materials |
|